Gabriel David Krygier-Waltier (Gabriel Krygier-Waltier, Gabriel Krygier, Gabriel Krygier Waltier)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Topics

Positive Breast Cancer

Sentinel Lymph Node

Epidermal Growth Factor Receptor

Clinical Practice

Top Venues

Revista medica del Instituto Mexicano del Seguro Social

World journal of oncology

Breast cancer (Dove Medical Press)

The breast journal

This page only lists publications with an associated author ORCID identifier.

Publications

Natalia Camejo-Martínez, Cecilia Castillo-Leska, Dahiana Lourdes Amarillo-Hernández, Heber de Los Santos, Gaston Samurio, Ahinara Silva-Marquez, Claudia Vera, Rocio Xavier, Guadalupe Herrera, Isabel Alonso, Gabriel David Krygier-Waltier
Efficacy of First-Line Treatment With Pertuzumab and Trastuzumab in Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in Routine Clinical Practice. World journal of oncology 15 (3) (2024)
Natalia Camejo-Martínez, Cecilia Castillo-Leska, Valeria Rodríguez-Saenz, Guadalupe Herrera, Dahiana Lourdes Amarillo-Hernández, María Carolina Dörner-Cabrera, Gabriel David Krygier-Waltier
[Cardiotoxicity from anti-HER-2 therapies in patients with HER-2 positive breast cancer]. Revista medica del Instituto Mexicano del Seguro Social 62 (1) (2024)
Natalia Camejo-Martínez, Cecilia Castillo-Leska, Valeria Rodríguez-Saenz, Guadalupe Herrera, Dahiana Lourdes Amarillo-Hernández, María Carolina Dörner-Cabrera, Gabriel David Krygier-Waltier
[Cardiotoxicity from anti-HER-2 therapies in patients with HER-2 positive breast cancer]. Revista medica del Instituto Mexicano del Seguro Social 62 (1) (2024)
Natalia Camejo-Martínez, Cecilia Castillo-Leska, Dahiana Lourdes Amarillo-Hernández, Heber de Los Santos, Gaston Samurio, Ahinara Silva-Marquez, Claudia Vera, Rocio Xavier, Guadalupe Herrera, Isabel Alonso, Gabriel David Krygier-Waltier
Efficacy of First-Line Treatment With Pertuzumab and Trastuzumab in Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in Routine Clinical Practice. World journal of oncology 15 (3) (2024)
Natalia Camejo-Martínez, Cecilia Castillo-Leska, Clara Tambasco, Noelia Strazzarino, Nicolas Requena, Silvina Peraza, Anna Boronat, Guadalupe Herrera, Patricia Esperón, Mauricio Cuello, Gabriel David Krygier-Waltier
Assessing Adherence to Adjuvant Hormone Therapy in Breast Cancer Patients in Routine Clinical Practice. World journal of oncology 14 (4) (2023)
Natalia Camejo-Martínez, Cecilia Castillo-Leska, Ana Laura Hernández-Ibero, Nora Amelia Artagaveytia-Cóppola, Dahiana Lourdes Amarillo-Hernández, Gabriel David Krygier-Waltier
[Returning to work after diagnosis and treatment of breast cancer]. Revista medica del Instituto Mexicano del Seguro Social 60 (5) (2022)
Cecilia Castillo-Leska, Natalia Camejo-Martínez, Monika Rondan, Florencia Savio, Guadalupe Herrera, Gabriel David Krygier-Waltier, Lucia Delgado
Survival and Time to Initiation of Adjuvant Chemotherapy Among Breast Cancer Patients in Uruguay. Breast cancer (Dove Medical Press) 13 (2021)
Maria Clara Rodriguez Palleiro, Gabriel David Krygier-Waltier
The impact of 21-Gene Recurrence Score test and classic clinical-pathologic factors in guiding adjuvant therapy for HER-2 negative, ER-positive, early-stage breast cancer: A retrospective study. The breast journal 26 (5) (2020)